426 results on '"WEDI, Bettina"'
Search Results
2. Zugelassene Therapien und ihre Wirkung auf die Leitsymptome der Urtikaria: Hilfreiche Therapieoptionen, wenn juckende Quaddeln nicht weichen – Viel hilft viel?
3. Urticaria in childhood—what’s new?
4. Meta-analysis of ACE inhibitor–induced angioedema identifies novel risk locus
5. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
6. Urticaria and Angioedema
7. Biologic therapy for chronic spontaneous urticaria in pediatrics and adolescents: current landscape, challenges, and future perspectives
8. Itching and swelling—but not only …
9. Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food
10. Penicillin-Toleranzinduktion in der Schwangerschaft: Allergologische Stellungnahme zur Empfehlung der aktuellen Leitlinie Diagnostik und Therapie der Syphilis (AWMF-Register-Nr. 059-002)
11. Expert consensus on practical aspects in the treatment of chronic urticaria
12. Urtikaria im Kindesalter - was gibt es Neues?
13. Fusion der Arbeitsgemeinschaft Allergologie der Deutschen Dermatologischen Gesellschaft (DDG) mit der Sektion Dermatologie der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) im Mai 2023 vollzogen
14. Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development
15. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
16. Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
17. Hypersensitivity reactions to biologics (part II): classifications and current diagnostic and treatment approaches
18. Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events
19. Urtikaria und Angioödem
20. Aktuelle Situation der allergologischen Versorgung an deutschen Kliniken
21. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
22. Current situation of allergological health care at German hospitals
23. Urticaria and Angioedema
24. Eignen sich kationisch-amphiphile H1-Antihistaminika zur adjuvanten Therapie des malignen Melanoms?
25. Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG)
26. Dipeptidylpeptidase-4-Inhibitoren (Gliptine) geraten in den Fokus
27. Guideline: Hereditary angioedema due to C1 inhibitor deficiency: S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft für Angioödeme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft für Innere Medizin, DGIM), German Society for Otorhinolaryngology (Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, DGHNO), German Society for Allergology and Clinical Immunology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI), German Society for Child and Adolescent Medicine (Deutsche Gesellschaft für Kinder- und Jugendmedizin, DGKJ), German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG), German Society for Pediatric Allergology and Environmental Medicine (Gesellschaft für Pädiatrische Allergologie und Umweltmedizin, GPA), German Association of ENT Surgeons (Deutscher Berufsverband der Hals-Nasen-Ohren-Ärzte, BVHNO), and the German HAE Patient Association (HAE-Vereinigung, Selbsthilfegruppe, HAE-SHG)
28. Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in Germany
29. Urticaria and Angioedema
30. Allergic Contact Dermatitis
31. S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie
32. S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline
33. Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria
34. Diagnosis and treatment of Hymenoptera venom allergy
35. S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline
36. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy
37. S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie
38. Guideline for allergological diagnosis of drug hypersensitivity reactions
39. Urticaria
40. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
41. Current diagnostics in NSAID hypersensitivity
42. Correction to: Guideline for the diagnosis of drug hypersensitivity reactions
43. Dermatitis update: clinical manifestations, pathogenesis and current therapeutic approaches
44. Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes
45. Management of suspected and confirmedCOVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
46. Therapy of Urticaria
47. Urticaria
48. Urticaria and Angioedema
49. Mastocytosis
50. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.